Now Reading: Molbio Diagnostics IPO opens today at Rs 768-807 per share
-
01
Molbio Diagnostics IPO opens today at Rs 768-807 per share
Molbio Diagnostics' IPO opens today at Rs 768-807 per share to raise up to Rs 940 crore. The company makes the Truenat portable diagnostic platform, endorsed by WHO for tuberculosis testing and…
The Story in Brief
Molbio Diagnostics' IPO opens today at Rs 768-807 per share to raise up to Rs 940 crore. The company makes the Truenat portable diagnostic platform, endorsed by WHO for tuberculosis testing and patented in over 100 countries. For FY26, it posted revenue of Rs 1,445 crore and net profit of Rs 164 crore, with over 80% of revenue from government and international aid agencies. Its top five customers contribute more than half of revenue, signalling concentration risk. Anchor investors including Goldman Sachs and BlackRock have already taken up Rs 281.5 crore. Brokerages recommend subscription for the long term, though valuation at 57 times earnings is steep. The grey market suggests a 16% listing gain, according to Mint.
The Indian Opinion
The Molbio IPO is riding high on a WHO-endorsed TB test and strong financial growth, but investors should not ignore the heavy reliance on government procurement and a thin client base. The promoters are selling a sizeable stake, and the valuation at 57 times earnings leaves little room for error. A more measured view would watch how the company diversifies beyond TB testing and into non-communicable diseases. The real test will be revenue growth from new assays in the next two years.
Sources (3): economictimes.indiatimes.com, thehindubusinessline.com, livemint.com
This story was synthesised by AI from the 3 sources linked above.
Updated: this story now draws on 3 sources.
